Stock comparison
Side-by-side financials for ELAB and MRK. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Market cap data is available for the leading company in this comparison.
Market value leader
MRK
Latest market capitalization comparison.
Revenue leader
MRK
ELAB: $590.08K vs MRK: $65.01B.
Profit leader
MRK
ELAB: -$7.75M vs MRK: $18.25B.
Margin leader
MRK
ELAB: -1313.0% vs MRK: 28.1% net margin.
| Metric | ELAB | MRK |
|---|---|---|
| Market cap | - | $308.78 B |
| US-listed rank | - | #45 |
| Revenue (latest FY) | $590.08K | $65.01B |
| Net income (latest FY) | -$7.75M | $18.25B |
| Net margin | -1313.0% | 28.1% |
| P/E (trailing FY) | - | 16.9x |
| SEC filings | 252 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Elevai Labs Inc. reported $590.08K in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Elevai Labs Inc. and Merck & Co., Inc., or browse the full rankings.